2fvj: Difference between revisions
Jump to navigation
Jump to search
m Protected "2fvj" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2fvj.png|left|200px]] | [[Image:2fvj.png|left|200px]] | ||
{{STRUCTURE_2fvj| PDB=2fvj | SCENE= }} | {{STRUCTURE_2fvj| PDB=2fvj | SCENE= }} | ||
===A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro=== | ===A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro=== | ||
{{ABSTRACT_PUBMED_16373399}} | {{ABSTRACT_PUBMED_16373399}} | ||
Revision as of 17:53, 26 July 2012
A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitroA novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro
Template:ABSTRACT PUBMED 16373399
About this StructureAbout this Structure
2fvj is a 2 chain structure of Peroxisome Proliferator-Activated Receptors with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Burgermeister E, Schnoebelen A, Flament A, Benz J, Stihle M, Gsell B, Rufer A, Ruf A, Kuhn B, Marki HP, Mizrahi J, Sebokova E, Niesor E, Meyer M. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro. Mol Endocrinol. 2006 Apr;20(4):809-30. Epub 2005 Dec 22. PMID:16373399 doi:10.1210/me.2005-0171